Effect of an interactive app on patient time to functional recovery (TFR) ongoing elective onco-logical liver resection (LR): The RECOLIV Trial – A Randomized Controlled Trial

Effect of an interactive app on patient time to functional recovery (TFR) ongoing elective onco-logical liver resection (LR): The RECOLIV Trial – A Randomized Controlled Trial - RECOLIV

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022159

Enrollment

Registered

2020-09-24

Start date

2021-02-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22 C78.7 C22.1

Interventions

Group 1: Group A (Control group): Elective oncological LR according to the standard of care without inter-active app usage (app will provide basis information and will be used to record patient report

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients scheduled for elective oncological LR are eligible for inclusion. Subjects matching the following criteria are eligible for inclusion into the clinical trial: • Primary or secondary liver malignancies • Age equal or greater than 18 years • Ability to understand the character and individual consequences of the clinical trial • Owner a mobile phone (Android or iOS) and possession of an email address • Written informed consent

Exclusion criteria

Exclusion criteria: • Extrahepatic resection required based on preoperative imaging • Significant cardiac or respiratory failure (ASA > 3) • Child C liver cirrhosis • Planned re-operation within 30 days after index operation • Impaired mental state or incompetence of understanding the German language (no fluent German language speakers) • Expected lack of compliance

Design outcomes

Primary

Measure	Time frame
Time to functional recovery	—

Secondary

Measure	Time frame
• Congruence of PRO regarding functional recovery compared to health care professional as-sessed outcomes • Patient-reported quality of recovery (QoR-15) • Health-related quality of life (HRQoL) • Patient satisfaction • General self-efficacy scale • Pulmonary embolism • Pulmonary infection • Renal failure • Delayed discharge time (DDT) • Post-discharge health care consumption (PDHCC) • Morbidity and mortality according to Clavien-Dindo classification at 90 days respectively comprehensive complication index (CCI) • App usage data	—

Measure

Time frame

• Congruence of PRO regarding functional recovery compared to health care professional as-sessed outcomes • Patient-reported quality of recovery (QoR-15) • Health-related quality of life (HRQoL) • Patient satisfaction • General self-efficacy scale • Pulmonary embolism • Pulmonary infection • Renal failure • Delayed discharge time (DDT) • Post-discharge health care consumption (PDHCC) • Morbidity and mortality according to Clavien-Dindo classification at 90 days respectively comprehensive complication index (CCI) • App usage data

—

Countries

Germany

Contacts

Public ContactPatrick;Christoph Téoule;Reißfelder

Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik;Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik

patrick.teoule@umm.de;christoph.reissfelder@umm.de+49621383-2225;+49 621 383 222

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026